These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 3556201)
1. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes. Van Amsterdam JG; Van Buuren KJ; Blad MW; Soudijn W Eur J Pharmacol; 1987 Mar; 135(3):411-8. PubMed ID: 3556201 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of enkephalin degrading enzymes by metal chelating reagents. Altstein M; Blumberg S; Vogel Z Adv Biochem Psychopharmacol; 1982; 33():261-70. PubMed ID: 6751033 [TBL] [Abstract][Full Text] [Related]
3. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors. Altstein M; Bachar E; Vogel Z; Blumberg S Eur J Pharmacol; 1983 Aug; 91(4):353-61. PubMed ID: 6352283 [TBL] [Abstract][Full Text] [Related]
4. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties. Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420 [TBL] [Abstract][Full Text] [Related]
5. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition. Patey G; De La Baume S; Schwartz JC; Gros C; Roques B; Fournie-Zaluski MC; Soroca-Lucas E Science; 1981 Jun; 212(4499):1153-5. PubMed ID: 7015510 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors of calf-brain enkephalinase A and B. van Amsterdam JG; van Buuren KJ; de Jong AM; Soudijn W Life Sci; 1983; 33 Suppl 1():109-12. PubMed ID: 6363851 [TBL] [Abstract][Full Text] [Related]
7. Effect of inhibitors of enkephalin degradation in the isolated guinea-pig ileum. van Amsterdam JG; van Buuren KJ; Krielaart MJ; Zuiderveld OP; Tijms RP Life Sci; 1988; 43(19):1529-36. PubMed ID: 3193845 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779 [TBL] [Abstract][Full Text] [Related]
9. Phelorphan, an inhibitor of enzymes involved in the biodegradation of enkephalins, affected the withdrawal symptoms in chronic morphine-dependent rats. Haffmans J; Walsum MV; van Amsterdam JC; Dzoljic MR Neuroscience; 1987 Jul; 22(1):233-6. PubMed ID: 2888045 [TBL] [Abstract][Full Text] [Related]
10. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes. Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348 [TBL] [Abstract][Full Text] [Related]
11. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492 [TBL] [Abstract][Full Text] [Related]
12. Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors. Fournie-Zaluski MC; Lucas E; Waksman G; Roques BP Eur J Biochem; 1984 Mar; 139(2):267-74. PubMed ID: 6321177 [TBL] [Abstract][Full Text] [Related]
13. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes. Hachisu M; Hiranuma T; Murata S; Aoyagi T; Umezawa H Life Sci; 1987 Jul; 41(2):235-40. PubMed ID: 3298909 [TBL] [Abstract][Full Text] [Related]
14. Differential recognition of "enkephalinase" and angiotensin-converting enzyme by new carboxyalkyl inhibitors. Fournié-Zaluski MC; Soroca-Lucas E; Waksman G; Llorens C; Schwartz JC; Roques BP Life Sci; 1982 Dec; 31(26):2947-54. PubMed ID: 6298535 [TBL] [Abstract][Full Text] [Related]
15. A highly sensitive fluorometric assay for "enkephalinase," a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins. Florentin D; Sassi A; Roques BP Anal Biochem; 1984 Aug; 141(1):62-9. PubMed ID: 6388410 [TBL] [Abstract][Full Text] [Related]
16. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme]. Roques BP J Pharmacol; 1985; 16 Suppl 1():5-31. PubMed ID: 2993752 [TBL] [Abstract][Full Text] [Related]
17. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan. Roques BP; Lucas-Soroca E; Chaillet P; Costentin J; Fournié-Zaluski MC Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3178-82. PubMed ID: 6304695 [TBL] [Abstract][Full Text] [Related]
18. Effect of various enkephalin analogs and dipeptides on the enzymatic activity of enkephalinase B isolated from calf-brain striatum. van Amsterdam JG; van Buuren KJ; Koomen AP; Soudijn W Life Sci; 1986 Mar; 38(12):1111-8. PubMed ID: 3515091 [TBL] [Abstract][Full Text] [Related]
19. Propioxatins A and B, new enkephalinase B inhibitors. IV. Characterization of the active site of the enzyme using synthetic propioxatin analogues. Inaoka Y; Naruto S J Biochem; 1988 Nov; 104(5):706-11. PubMed ID: 3069842 [TBL] [Abstract][Full Text] [Related]
20. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition. Chérot P; Devin J; Fournié-Zaluski MC; Roques BP Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]